Detalles de la búsqueda
1.
Safety and impact of dose reductions on efficacy in the randomised MONALEESA-2, -3 and -7 trials in hormone receptor-positive, HER2-negative advanced breast cancer.
Br J Cancer
; 125(5): 679-686, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34158598
2.
Phase Ib Dose-escalation/Expansion Trial of Ribociclib in Combination With Everolimus and Exemestane in Postmenopausal Women with HR+, HER2- Advanced Breast Cancer.
Clin Cancer Res
; 26(24): 6417-6428, 2020 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32998962
Resultados
1 -
2
de 2
1
Próxima >
>>